1. Home
  2. GPMT vs BDTX Comparison

GPMT vs BDTX Comparison

Compare GPMT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$1.40

Market Cap

119.9M

Sector

Real Estate

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
BDTX
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.9M
116.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GPMT
BDTX
Price
$1.40
$2.03
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$3.00
$10.20
AVG Volume (30 Days)
140.1K
571.5K
Earning Date
05-05-2026
03-16-2026
Dividend Yield
13.61%
N/A
EPS Growth
N/A
130.71
EPS
N/A
0.39
Revenue
N/A
N/A
Revenue This Year
$422.75
N/A
Revenue Next Year
$34.54
N/A
P/E Ratio
N/A
$5.46
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$1.20
52 Week High
$3.12
$4.94

Technical Indicators

Market Signals
Indicator
GPMT
BDTX
Relative Strength Index (RSI) 23.64 39.11
Support Level N/A $1.93
Resistance Level $1.83 $2.30
Average True Range (ATR) 0.07 0.11
MACD 0.00 -0.00
Stochastic Oscillator 4.35 1.82

Price Performance

Historical Comparison
GPMT
BDTX

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: